India's Drugmaking Ambitions Suffer a Big SetbackBy
Would you trust Made-in-India medicines? For years, the country’s pharmaceutical companies have been betting that consumers worldwide would be happy to buy low-cost drugs from India. Just as IT services companies such as Infosys and Tata Consultancy Services became outsourcing powers by providing inexpensive ways to do work offshore, pharma companies from India have tried to take advantage of the country’s big supply of low-cost, high-skilled workers to make medicines.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.